Back to News
Dec 31, 2025 4:50 PM

Alvotech Secures Term Loan Facility of USD 100 Million

USD 100 million senior term loan facility with a 2-year maturity

Strengthens liquidity to support execution across Alvotech's R&D pipeline and global product launches through 2026

Led by GoldenTree Asset Management

REYKJAVIK, Iceland, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity in December 2027 aimed at strengthening liquidity and supporting the execution of Alvotech's strategic priorities in 2026.

"This USD 100 million financing underscores the long-term commitment of our financing partners at GoldenTree and their alignment with Alvotech's strategy," said Robert Wessman, Chairman and CEO of Alvotech. "Their support strengthens our ability to execute on our growth plans, invest in R&D, and deliver high-quality biosimilars to patients worldwide."

With the transaction, led by GoldenTree Asset Management, Alvotech secures financing from investors who share the Company's confidence in its ability to execute, and the scale, quality and commercial potential of its biosimilar product pipeline. Alvotech remains committed to advancing its R&D pipeline, which currently includes 30 products in development and ranks among the most valuable biosimilar portfolios in the industry. In parallel, the Company continues to expand its production capacity and strengthen its supply chain to support four new global product launches through 2026.

The transaction, a senior term loan facility in an aggregate principal amount of USD 100 million, bears an interest rate of 12.50%, payable monthly in cash, and has a maturity date of 2 years. The transaction replaces the Company's previously disclosed working capital facility (ABL) and provides Alvotech with access to the full USD 100 million throughout the term of the loan. This structure offers enhanced operational flexibility.

This term loan facility follows the successful arrangement ...